Valley Brook Capital Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.23M | Sell |
22,792
-125
| -0.5% | -$23.2K | 3.17% | 7 |
|
|
2025
Q1 | $4.8M | Buy |
22,917
+218
| +1% | +$45.7K | 3.77% | 3 |
|
|
2024
Q4 | $4.03M | Sell |
22,699
-88
| -0.4% | -$15.6K | 3.01% | 6 |
|
|
2024
Q3 | $4.5M | Sell |
22,787
-58
| -0.3% | -$11.5K | 3.23% | 4 |
|
|
2024
Q2 | $3.92M | Buy |
22,845
+96
| +0.4% | +$16.5K | 3.05% | 5 |
|
|
2024
Q1 | $4.14M | Sell |
22,749
-96
| -0.4% | -$17.5K | 3.31% | 4 |
|
|
2023
Q4 | $3.54M | Buy |
22,845
+128
| +0.6% | +$19.8K | 3.08% | 4 |
|
|
2023
Q3 | $3.39M | Buy |
22,717
+468
| +2% | +$69.8K | 3.35% | 4 |
|
|
2023
Q2 | $3M | Sell |
22,249
-891
| -4% | -$120K | 2.77% | 5 |
|
|
2023
Q1 | $3.69M | Sell |
23,140
-239
| -1% | -$38.1K | 3.4% | 4 |
|
|
2022
Q4 | $3.78M | Buy |
23,379
+357
| +2% | +$57.7K | 3.62% | 4 |
|
|
2022
Q3 | $3.09M | Buy |
23,022
+107
| +0.5% | +$14.4K | 3.37% | 5 |
|
|
2022
Q2 | $3.51M | Sell |
22,915
-400
| -2% | -$61.3K | 3.62% | 5 |
|
|
2022
Q1 | $3.78M | Buy |
23,315
+1,206
| +5% | +$195K | 3.26% | 4 |
|
|
2021
Q4 | $2.99M | Buy |
22,109
+208
| +0.9% | +$28.2K | 2.58% | 6 |
|
|
2021
Q3 | $2.36M | Sell |
21,901
-1,123
| -5% | -$121K | 2.34% | 9 |
|
|
2021
Q2 | $2.59M | Buy |
23,024
+627
| +3% | +$70.6K | 2.47% | 8 |
|
|
2021
Q1 | $2.42M | Buy |
22,397
+610
| +3% | +$66K | 2.19% | 8 |
|
|
2020
Q4 | $2.33M | Buy |
+21,787
| New | +$2.33M | 2.31% | 6 |
|